Prostatitis aguda bacteriana (PAB) por Escherichia coli multirresitente. research hub

FOSFOMYCIN AS AN ORAL ALTERNATIVE THERAPY IN THE TREATMENT OF ACUTE BACTERIAL PROSTATITIS CAUSED BY MULTIDRUG-RESISTANT ESCHERICHIA COLI. PILOT STUDY

This study is looking at whether an antibiotic called fosfomycin can effectively treat a specific type of prostate infection in men. It's for men who have had some initial hospital treatment and have an infection caused by certain bacteria that are hard to treat with other medicines.